Business Description
Ortin Laboratories Ltd
ISIN : INE749B01020
Compare
Compare
Traded in other countries / regions
539287.India IPO Date
2007-04-12Description
Ortin Laboratories Ltd is an India based engaged in the manufacturing and trading of Pharmaceuticals, Drugs, and Intermediates. Its formulations include anti-diabetics, anti-allergics, anti-anginal and cardiovascular, sedatives and tranquilisers, anti-helmenthetics, analgesics and antipyretics, antibiotics, antifungal, cephalosporins, and others. Some of its APIs Intermediates include Ciprofloxacin, Tramadol, Efavarenz, Lamivudine, Zudavudine, Nevirapine, Lopinavir, Fluconazole, Triclabendazole, Omeprazole, and others.It earns key revenue from domestic sales.
Financial Strength
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 1.3 | |||||
Equity-to-Asset | 0.43 | |||||
Debt-to-Equity | 0.64 | |||||
Debt-to-EBITDA | -0.28 | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | 0.48 | |||||
Beneish M-Score | -5.86 | |||||
WACC vs ROIC |
Growth Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -36.2 | |||||
3-Year Book Growth Rate | -37.1 |
Momentum Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 63.78 | |||||
9-Day RSI | 61.42 | |||||
14-Day RSI | 59.64 | |||||
6-1 Month Momentum % | -26.91 | |||||
12-1 Month Momentum % | -22 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 3.11 | |||||
Quick Ratio | 3.09 | |||||
Cash Ratio | 1.15 | |||||
Days Inventory | 168.29 | |||||
Days Sales Outstanding | 326.95 | |||||
Days Payable | 62.26 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Shareholder Yield % | 16.51 |
Profitability Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | -75.95 | |||||
Operating Margin % | -312.2 | |||||
Net Margin % | -380.82 | |||||
FCF Margin % | -173.88 | |||||
ROE % | -102.87 | |||||
ROA % | -52.42 | |||||
ROIC % | -53.49 | |||||
ROC (Joel Greenblatt) % | -57.04 | |||||
ROCE % | -62.91 | |||||
Years of Profitability over Past 10-Year | 6 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 8.02 | |||||
PB Ratio | 5.96 | |||||
Price-to-Tangible-Book | 5.96 | |||||
EV-to-EBIT | -2.47 | |||||
EV-to-EBITDA | -2.56 | |||||
EV-to-Revenue | 7.72 | |||||
EV-to-FCF | -4.44 | |||||
Price-to-Projected-FCF | 0.57 | |||||
Price-to-Net-Current-Asset-Value | 6.54 | |||||
Earnings Yield (Greenblatt) % | -40.49 | |||||
FCF Yield % | -21.81 | |||||
Forward Rate of Return (Yacktman) % | -20.19 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Ortin Laboratories Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil ₹) | 21.115 | ||
EPS (TTM) (₹) | -9.89 | ||
Beta | 0.54 | ||
Volatility % | 40.77 | ||
14-Day RSI | 59.64 | ||
14-Day ATR (₹) | 0.962284 | ||
20-Day SMA (₹) | 19.728 | ||
12-1 Month Momentum % | -22 | ||
52-Week Range (₹) | 16.15 - 26.39 | ||
Shares Outstanding (Mil) | 8.13 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 3 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Ortin Laboratories Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Ortin Laboratories Ltd Stock Events
Event | Date | Price(₹) | ||
---|---|---|---|---|
No Event Data |
Ortin Laboratories Ltd Frequently Asked Questions
What is Ortin Laboratories Ltd(BOM:539287)'s stock price today?
The current price of BOM:539287 is ₹20.70. The 52 week high of BOM:539287 is ₹26.39 and 52 week low is ₹16.15.
When is next earnings date of Ortin Laboratories Ltd(BOM:539287)?
The next earnings date of Ortin Laboratories Ltd(BOM:539287) is .
Does Ortin Laboratories Ltd(BOM:539287) pay dividends? If so, how much?
Ortin Laboratories Ltd(BOM:539287) does not pay dividend.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |